Precision in cancer pharmacogenomics

Pharmacogenomics. 2020 Apr;21(5):311-316. doi: 10.2217/pgs-2020-0011. Epub 2020 Apr 3.

Authors

Ioannis D Kyrochristos^{1

2}, Evangelos G Baltagiannis^{1

2}, Michail Mitsis^{2

3}, Dimitrios H Roukos^{1

2

4}

Affiliations

¹ Centre for Biosystems & Genome Network Medicine, Ioannina University, Ioannina, Greece.
² Department of Surgery, University Hospital of Ioannina, Ioannina, Greece.
³ Cancer Biobank Centre, Ioannina University, Ioannina, Greece.
⁴ Department of Systems Biology, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.

PMID: 32242500
DOI: 10.2217/pgs-2020-0011

No abstract available

Keywords: cancer pharmacogenomics; genome engineering; next-generation sequencing; novel drug discovery.

Publication types

Editorial

MeSH terms

Humans
Neoplasms* / drug therapy
Neoplasms* / genetics
Pharmacogenetics*
Precision Medicine